Objectives: The aim of this Belgian research study was to describe the characteristics of physicians who are at increased risk for patient-physician aggression. Second, aggression subtypes were described and data were provided on the prevalence of patient-physician aggression in Belgium.

Design: Cross-sectional survey.

Setting: Primary and secondary care inside and outside hospitals.

Participants: Any physician who had worked in Belgium for the preceding 12 months was eligible to participate (n=34 648).

Main Outcome Measures: An online, original questionnaire was used to obtain physician characteristics (eg, age, sex, native language), department, working conditions and contact with aggressive patients during their career and during the preceding 12 months.

Results: The questionnaire was completed by 4930 participants and 3726 (76%) were valid to take into account for statistics. During the preceding 12 months, 37% had been victims of aggression: 33% experienced verbal aggression, 30% psychological, 14% physical and 10% sexual. Multiple answers were allowed. Women and younger physicians were more likely to experience aggression. Psychiatric departments and emergency departments were the settings most commonly associated with aggression. Physicians who provided primarily outpatient care were more subject to aggression.

Conclusion: Belgian physicians experience several forms of aggression. Those most at-risk of aggression are young and female physicians who work in outpatient, emergency or psychiatric settings.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937035PMC
http://dx.doi.org/10.1136/bmjopen-2018-025942DOI Listing

Publication Analysis

Top Keywords

patient-physician aggression
12
aggression
11
physician characteristics
8
preceding months
8
physicians experience
8
physicians
5
cross-sectional study
4
study patient-physician
4
aggression belgium
4
belgium physician
4

Similar Publications

Background: Early palliative care interventions in oncology, as recommended by international oncology societies, promote patient understanding and support decision-making. At the same time, shared decision-making models are being developed to enhance patient participation as part of a new model of patient-physician relationship. For patients with palliative needs, this participation is essential and helps to avoid futile and aggressive treatments at the end of life.

View Article and Find Full Text PDF

Background: Ki67 index (KI) and mitotic index (MI) are proliferation markers with established prognostic value in breast carcinomas. While KI is evaluated immunohistochemically and reported as a percentage, MI is determined visually and reflects total mitotic cells in 10 high-power fields. Our objective was to integrate KI and MI into a novel metric; the cell cycle traverse rate (CCTR).

View Article and Find Full Text PDF

It has been shown that magnetic resonance imaging (MRI) guidance versus computed tomography (CT) guidance for aggressive margin-reduction (AMR) for stereotactic body radiotherapy (SBRT) in prostate cancer reduces acute toxicity, but the longer-term benefits are unknown. We performed a secondary analysis of MIRAGE, a phase 3 randomized clinical trial of MRI-guided SBRT for prostate cancer, to determine whether AMR with MRI guidance significantly reduced 2-yr physician-scored or patient-reported toxic effects in comparison to CT guidance. The cumulative incidence of 2-yr physician-scored toxicity, defined as grade ≥2 genitourinary (GU) and gastrointestinal (GI) toxic effects according to Common Terminology Criteria for Adverse Events v4.

View Article and Find Full Text PDF

Dermatofibrosarcoma protuberans (DFSP) is a rare malignancy of mesenchymal origin of medium-low grade with a tendency to local recurrences but not to distant metastases. We present the case of a 37-year-old male who underwent surgical resection of a 1.2 cm DFSP lesion on the left shoulder in May 2020.

View Article and Find Full Text PDF
Article Synopsis
  • Biopolymers are synthetic materials used as fillers but are not compatible with the body, potentially leading to adverse reactions and conditions known as foreign-body-induced human adjuvant disease.
  • A study conducted in Bogotá, Colombia, involved 20 patients who had biopolymer removal surgeries, revealing significant inflammatory responses and signs that could complicate diagnosis, like cytoplasmic vacuolization in reactive adipocytes.
  • It is advised that surgeons measure certain blood markers (lactate dehydrogenase, serum calcium, and parathyroid hormone) to evaluate complications, and that removing biopolymers surgically may help prevent further issues.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!